A18.0 Tuberculosis of bones and joints

Name of the Condition

• Tuberculosis of bones and joints
• ICD Code: A18.0

Summary

Tuberculosis of bones and joints is a form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects the skeletal system, including bones and joints. This condition typically results from the spread of TB bacteria from a primary site, most commonly the lungs, via the bloodstream or lymphatic system. It can affect any part of the skeleton but often involves the spine, hips, knees, or other weight-bearing joints.

Causes

Tuberculosis of bones and joints is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria may travel to the skeletal system during active disease or reactivation of latent TB. Direct inoculation is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic immunosuppressive therapy.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes, malnutrition, or chronic kidney disease.

Symptoms

• Persistent localized pain, often worsening at night or with movement.
• Stiffness or reduced range of motion in affected joints.
• Swelling or warmth around the affected area.
• Systemic symptoms of TB, such as fever, night sweats, or unexplained weight loss.
• In spinal involvement, potential neurological symptoms like weakness or numbness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A thorough medical history and physical examination are essential. Imaging studies, such as X-rays, MRI, or CT scans, may reveal characteristic changes like bone destruction or joint space narrowing. Laboratory confirmation typically requires culture or molecular testing of tissue or fluid samples from the affected site.

Treatment Options

Treatment follows standard anti-tuberculosis therapy (ATT), including a combination of drugs like isoniazid, rifampicin, ethambutol, and pyrazinamide. The duration of therapy is usually 6-12 months, depending on the severity and response. Surgical intervention may be necessary in cases of severe bone destruction, abscess formation, or spinal instability.

Prognosis and Follow-Up

With appropriate treatment, most patients achieve full recovery. However, delays in diagnosis or treatment can lead to permanent joint damage or deformity. Regular follow-up is critical to monitor treatment response, manage side effects, and detect complications early. Long-term rehabilitation may be required to restore function.

Complications

• Chronic pain or joint deformity.
• Spinal cord compression or neurological deficits (in spinal TB).
• Bone destruction or pathological fractures.
• Joint stiffness or reduced mobility.
• Recurrence of infection if treatment is incomplete.

Lifestyle & Prevention

• Ensure completion of prescribed TB treatment to prevent dissemination.
• Maintain good nutrition and overall health to support immune function.
• Avoid close contact with individuals who have active TB, especially in high-prevalence areas.
• Follow public health guidelines for TB screening and prevention, particularly if immunocompromised.

When to Seek Professional Help

Seek medical attention if you experience persistent joint pain, unexplained fever, night sweats, or weight loss, especially if you have a history of TB exposure or infection. Prompt evaluation is crucial to prevent irreversible damage.

Tips for Medical Coders

When coding A18.0, ensure documentation specifies the affected bones or joints (e.g., spinal TB, hip TB) to support the diagnosis. Verify that the condition is confirmed by appropriate clinical or laboratory evidence. Note any associated complications or treatment details, as these may impact coding specificity.